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Jarod Wolffis
Mentor – Dr. Sheri Holmen
Nevada Cancer Institute
Melanoma is the most rapidly increasing malignancy among young people in the
United States. If detected early, the disease is easily treated; however, once the
disease has metastasized it is largely refractory to conventional therapies and is
associated with a high mortality rate. The development of human cancer from a
pre-malignant primary tumor to a metastatic lesion that develops at secondary
sites is thought to be a multi-step process, requiring many genetic and epigenetic
events that provide a growth advantage to cells. It is still unclear which of the
many genetic changes in human cancers are required for metastasis. Therefore,
it is critical to evaluate each step in the metastatic process. To this end, we will
generate novel lentiviral vectors containing fluorescent reporter genes to better
understand the metastatic potential of melanoma cells. Vectors containing green
fluorescent protein (GFP) have already been generated while vectors containing
red fluorescent protein (RFP) and yellow fluorescent protein (YFP) will be cloned.
Viruses will be generated and used to infect syngeneic explanted tumor cells.
Since each vector will be marked with a reporter gene of a different color, we will
be able to track the movement of these cells in vivo and determine the source of
each metastatic tumor. Whole body fluorescence will be detected using the
FluorVivo Imaging System (INDEC BioSystems, Santa Clara, CA). The
experiments proposed will contribute to an increased understanding of the
biology of melanoma, which has the potential to identify specific molecular
targets and promote the development of more effective therapies for advanced
stages of this disease.
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